trial

Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women?

NCTId NCT00206544
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Completed
Enrollment 51 (actual)
Sponsored by The Alfred
Primary completion 2007-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Completed
Enrollment
51 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2004-01
Primary completion
2007-12
Eligibility
FEMALE · 18 Years · 50 Years

Interventions & indications

Drugs
TamoxifenProgesterone

Sponsors

The AlfredLead Sponsor
Stanley Medical Research InstituteCollaborator
National Health and Medical Research Council, AustraliaCollaborator

Investigators

1
Jayashri Kulkarni, MBBS, MPM, FRANZCP, PHDPrincipal Investigator

Sites

1 total
Melbourne, Australia

Linked catalysts

1
Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women? — primary completion2007-12

Facts & assertions

4 sourced
Enrollment
51
Phase
PHASE2
Primary Completion Date
2007-12
Status
COMPLETED
relationships
The graph out of here
drug
Tamoxifen
drug
Progesterone
drug
lead_sponsor
The Alfred
company
collaborator
Stanley Medical Research Institute
company
National Health and Medical Research Council, Australia
company
indication
Mania
indication
Bipolar Disorder
indication
Mania
indication
investigator
Jayashri Kulkarni, MBBS, MPM, FRANZCP, PHD
person